Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

Morgan Stanley Maintains Overweight on Freeport-McMoRan, Lowers Price Target to $46

Author: Benzinga Newsdesk | October 08, 2025 08:28am
Morgan Stanley analyst Carlos De Alba maintains Freeport-McMoRan (NYSE:FCX) with a Overweight and lowers the price target from $48 to $46.

Posted In: FCX

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist